231 related articles for article (PubMed ID: 10985971)
1. Histomorphological features of chorionic villi at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies.
Roberts L; Sebire NJ; Fowler D; Nicolaides KH
Placenta; 2000 Sep; 21(7):678-83. PubMed ID: 10985971
[TBL] [Abstract][Full Text] [Related]
2. Short communication: trophoblast proliferation is increased in chorionic villi from pregnancies with fetal trisomy 18.
Sebire NJ; Fowler D; Roberts L; Mahmood S; Nicolaides KH
Placenta; 2000; 21(5-6):584-6. PubMed ID: 10940209
[TBL] [Abstract][Full Text] [Related]
3. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
4. Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation.
Kagan KO; Anderson JM; Anwandter G; Neksasova K; Nicolaides KH
Prenat Diagn; 2008 Dec; 28(13):1209-13. PubMed ID: 19039823
[TBL] [Abstract][Full Text] [Related]
5. Trisomy 7 CVS mosaicism: pregnancy outcome, placental and DNA analysis in 14 cases.
Kalousek DK; Langlois S; Robinson WP; Telenius A; Bernard L; Barrett IJ; Howard-Peebles PN; Wilson RD
Am J Med Genet; 1996 Nov; 65(4):348-52. PubMed ID: 8923948
[TBL] [Abstract][Full Text] [Related]
6. Confined placental mosaicism for trisomies 2, 3, 7, 8, 9, 16, and 22: their incidence, likely origins, and mechanisms for cell lineage compartmentalization.
Wolstenholme J
Prenat Diagn; 1996 Jun; 16(6):511-24. PubMed ID: 8809892
[TBL] [Abstract][Full Text] [Related]
7. Histomorphometric characterisation of shared and non-shared cotyledonary villus territories of monochorionic placentae in relation to pregnancy complications.
Wee LY; Sebire NJ; Bhundia J; Sullivan M; Fisk NM
Placenta; 2006; 27(4-5):475-82. PubMed ID: 16023205
[TBL] [Abstract][Full Text] [Related]
8. Invasive testing for the karyotyping of mid-trimester intrauterine fetal death (IUFD): a pilot study.
Howarth ES; Konje JC; Healey KA; Duckett DP; Scudamore IW; Taylor DJ
Prenat Diagn; 2002 Jun; 22(6):453-5. PubMed ID: 12116301
[TBL] [Abstract][Full Text] [Related]
9. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Valencia C; Maiz N; Nicolaides KH
Hum Reprod; 2008 Sep; 23(9):1968-75. PubMed ID: 18544579
[TBL] [Abstract][Full Text] [Related]
10. Specific transcriptional changes in human fetuses with autosomal trisomies.
Altug-Teber O; Bonin M; Walter M; Mau-Holzmann UA; Dufke A; Stappert H; Tekesin I; Heilbronner H; Nieselt K; Riess O
Cytogenet Genome Res; 2007; 119(3-4):171-84. PubMed ID: 18253026
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic evidence for enhanced selective miscarriage of trisomy 21 pregnancies with advancing maternal age.
Kratzer PG; Golbus MS; Schonberg SA; Heilbron DC; Taylor RN
Am J Med Genet; 1992 Nov; 44(5):657-63. PubMed ID: 1481829
[TBL] [Abstract][Full Text] [Related]
12. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
13. A quantitative analysis of placental vasculature in the third-trimester fetus with autosomal trisomy.
Rochelson B; Kaplan C; Guzman E; Arato M; Hansen K; Trunca C
Obstet Gynecol; 1990 Jan; 75(1):59-63. PubMed ID: 2296424
[TBL] [Abstract][Full Text] [Related]
14. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
[TBL] [Abstract][Full Text] [Related]
15. Placental volume measured by three-dimensional ultrasound at 11 to 13 + 6 weeks of gestation: relation to chromosomal defects.
Wegrzyn P; Faro C; Falcon O; Peralta CF; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Jul; 26(1):28-32. PubMed ID: 15937964
[TBL] [Abstract][Full Text] [Related]
16. Transabdominal chorionic villus sampling at 9.5-12 weeks' gestation. Placental vascular resistance and fetal cardiovascular responses.
Kofinas AD; D'Amico K; McGuiness T; Clay D; King K
J Reprod Med; 1995 Jun; 40(6):453-7. PubMed ID: 7650660
[TBL] [Abstract][Full Text] [Related]
17. Acid-base and hematologic values at blood sampling in the evaluation of trisomic fetuses: a case-control study.
Extermann P; Nicolini U; Rodeck CH
Obstet Gynecol; 1993 Jun; 81(6):958-62. PubMed ID: 8497363
[TBL] [Abstract][Full Text] [Related]
18. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies.
Bindra R; Heath V; Liao A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2002 Sep; 20(3):219-25. PubMed ID: 12230441
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis of trisomy 20 by chorionic villus sampling (CVS): a case report with long-term outcome.
Steinberg Warren N; Soukup S; King JL; St J Dignan P
Prenat Diagn; 2001 Dec; 21(13):1111-3. PubMed ID: 11787033
[TBL] [Abstract][Full Text] [Related]
20. Trisomy 9 confined to the placenta: prenatal diagnosis and neonatal follow-up.
Appelman Z; Rosensaft J; Chemke J; Caspi B; Ashkenazi M; Mogilner MB
Am J Med Genet; 1991 Sep; 40(4):464-6. PubMed ID: 1746612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
